MedPath

Clinical Phase II Study of hematopoietic stem ctell transplantation for ataxia telangiectasia and related diseases

Not Applicable
Recruiting
Conditions
ataxia telangiectasia DNA damage response disorder
Registration Number
JPRN-UMIN000019532
Lead Sponsor
Graduate Schoool, Dept. of Community Pediatrics, Perinatal and Maternal Medicine, Tokyo Medical and Dental University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

multiple organs failure intra cranial hemorrhage heart failure renal failure uncontrolled infection uncontrolled diabetes lever cirrhosis serious psychological problem

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
overall survival for 1 year
Secondary Outcome Measures
NameTimeMethod
percentage of adverse effect
© Copyright 2025. All Rights Reserved by MedPath